Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC14015 structure
    GC14015Lenalidomide hydrochloride
    CAS: 1243329-97-6

    An analog of thalidomide

  • GC14451 structure
    GC14451GDC-0152
    CAS: 873652-48-3
    纯度: >99.50%

    An inhibitor of IAPs

  • GC16695 structure
    GC16695Bax inhibitor peptide, negative control
    CAS: 1315378-74-5

    Peptide inhibit Bax translocation to mitochondria

  • GC11569 structure
    GC11569Obatoclax mesylate (GX15-070)
    CAS: 803712-79-0
    纯度: >99.50%

    An antagonist of pro-survival Bcl-2 proteins

  • GC14065 structure
    GC14065Capsaicin
    CAS: 404-86-4
    纯度: >99.50%

    辣椒素是一种高度选择性的瞬时受体电位阳离子通道激动剂,亚家族 V,成员 1 (TRPV1),一种配体门控的非选择性阳离子通道,优先在小直径感觉神经元上表达 。

  • GC14291 structure
    GC14291LCL161
    CAS: 1005342-46-0
    纯度: >99.50%

    A Smac mimetic and inhibitor of IAP family proteins

  • GC10896 structure
    GC10896Cyclic Pifithrin-α hydrobromide
    CAS: 511296-88-1
    纯度: >98.00%

    A stable inhibitor of p53

  • GC11065 structure
    GC11065Pifithrin-μ
    CAS: 64984-31-2
    纯度: >98.00%

    Pifithrin-μ是p53和HSP70的抑制剂。

  • GP10028 structure
  • GP10036 structure
  • GC10160 structure
    GC10160Apoptosis Inhibitor
    CAS: 54135-60-3
    纯度: >97.50%

    A cell-permeable inhibitor of caspase-3 activation

  • GC12407 structure
    GC12407Z-IETD-FMK
    CAS: 210344-98-2
    纯度: >98.00%

    Z-IETD-FMK(Z-IE(OMe)TD(OMe)-FMK)是一种选择性和细胞可渗透的 caspase-8抑制剂。

  • GC16990 structure
    GC16990Z-LEHD-FMK
    CAS: 210345-04-3
    纯度: >98.00%

    Z-LEHD-FMK是一种不可逆的caspase-9抑制剂。

  • GC17874 structure
    GC17874Matrine
    CAS: 519-02-8
    纯度: >98.00%

    苦参碱(Matrine)是一种存在于槐属植物中的生物碱,可作为 kappa 阿片受体和μ-受体激动剂。

  • GC12190 structure
    GC12190Z-WEHD-FMK
    CAS: 210345-00-9
    纯度: >98.50%

    Z-WEHD-FMK 是一种有效的、细胞渗透性和不可逆的 caspase-1/5 抑制剂。 Z-WEHD-FMK 还表现出对组织蛋白酶 B 活性的强大抑制作用 (IC50=6 μM)。 Z-WEHD-FMK 可用于研究细胞凋亡的证据。

  • GC10153 structure
    GC10153Sabutoclax
    CAS: 1228108-65-3

    A pan-Bcl-2 inhibitor

  • GC10258 structure
    GC10258Ac-IEPD-AFC
    CAS: 1135417-31-0

    Ac-IEPD-AFC 是颗粒酶 B 的底物。

  • GC10315 structure
    GC10315Plumbagin
    CAS: 481-42-5
    纯度: >99.50% / >98.50%

    A natural naphthoquinone

  • GC10968 structure
    GC10968Ac-LEHD-AFC
    CAS: 210345-03-2

    A caspase-4, -5, and -9 fluorogenic substrate

  • GC11908 structure
    GC11908Cisplatin
    CAS: 15663-27-1
    纯度: >98.00% / >99.00% / >99.50%

    顺铂是最好的、最早的基于金属的化疗药物之一,用于治疗广泛的实体癌症,如睾丸癌、卵巢癌、膀胱癌、肺癌、宫颈癌、头颈部肿瘤和胃癌等。

  • GC12258 structure
    GC122582,3-DCPE hydrochloride
    CAS: 418788-90-6

    2,3-DCPE 是一种促凋亡化合物,对癌细胞\u003cem\u003e相对于\u003c/em\u003e正常人细胞具有选择性

  • GC12701 structure
    GC12701NSC 207895 (XI-006)
    CAS: 58131-57-0
    纯度: >98.00%

    An inhibitor of MDMX

  • GC13473 structure
    GC13473Lenalidomide hemihydrate
    CAS: 847871-99-2
    纯度: >99.50%

    An analog of thalidomide

  • GC13498 structure
    GC13498BM-1074
    CAS: 1391108-10-3

    BM-1074 是一种有效且特异性的 Bcl-2/Bcl-xL 抑制剂,对 Bcl-2 和 Bcl-xL 的 Ki 值 < 1 nM,IC50 值分别为 1.8 nM 和 6.9 nM。 BM-1074 诱导细胞凋亡,并对四种小细胞肺癌细胞系(H146、H1963、H187 和 H1417)具有抗增殖活性,IC50 值为 1-2 nM。